missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ TrueGuide™ sgRNA Positive Control, CDK4 (human)

Product Code. 31662804
missing translation for 'orderingAttributeHoverText'
Quantity:
3 nmol

Produktkod. 31662804

missing translation for 'mfr': Invitrogen™ A35523

Please to purchase this item. Need a web account? Register with us today!

Used for the optimization of transfection and verification of editing efficiency in transfected cells.

Provides complete collection of validated positive controls for the TrueGuide Synthetic gRNA product line to help maximize editing performance. This positive control against CDK4 targets region of Exon 2 and has achieved editing efficiencies of up to 80% in variety of human cell lines. CDK4 control easily determines the optimal conditions for delivering CRISPR/Cas9 tools to cell type, allowing to move forward in editing experiments and minimize downstream effort to isolate and validate your edited clones.

Validated positive control sgRNA targeting CDK4

TRUSTED_SUSTAINABILITY

Specifikationer

Content And Storage Delivered as dried RNA. Store dried RNA at room temperature; store resuspended RNA at -5°C to -30°C. Resuspend in nuclease-free water or TE.
Format Tube
Control Type Positive Control
RNAi Type gRNA
Species Human
Product Line TrueGuide™
Product Type gRNA
Quantity 3 nmol
Shipping Condition Room Temperature

For Research Use Only. Not for use in diagnostic procedures.

Korrigering av produktinnehåll

Din input är viktig för oss. Fyll i det här formuläret för att ge feedback relaterad till innehållet på denna produkt.

Produkttitel

Genom att klicka på Skicka bekräftar du att du kan bli kontaktad av Fisher Scientific angående feedbacken du har lämnat i detta formulär. Vi kommer inte att dela din information för andra ändamål. All kontaktinformation som tillhandahålls ska också underhållas i enlighet med vår Sekretesspolicy.

Tack! Din feedback har skickats. Fisher Scientific arbetar alltid för att förbättra vårt innehåll åt dig. Vi uppskattar din feedback.